Edition:
United States

People: Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.61USD
23 Jul 2018
Change (% chg)

$0.05 (+1.95%)
Prev Close
$2.56
Open
$2.55
Day's High
$2.61
Day's Low
$2.55
Volume
6,682
Avg. Vol
8,816
52-wk High
$3.64
52-wk Low
$2.00

Smith, Angus 

Mr. Angus Smith is Senior Vice President, Chief Business Officer and Principal Financial Officer of the Company. Mr. Smith joined the Company in September 2014 as Vice President, M&A and Corporate Finance and was appointed Vice President, Business Development & Strategic Planning of the Company in July 2016. Prior to joining the Company, Mr. Smith served as a Director in the Healthcare Investment Banking Group at Cantor Fitzgerald, a financial services firm, where he worked from October 2011 to September 2014. Mr. Smith previously held several positions of increasing responsibility in the Healthcare Investment Banking group at Gleacher & Company, a financial advisory firm, and various predecessor firms from July 2005 to August 2011. During his Investment Banking tenure, Mr. Smith worked on a variety of transactions, providing advice to specialty pharmaceutical and healthcare companies regarding mergers and acquisitions, initial public offerings, follow-on offerings, debt offerings, private placements and debt restructuring transactions. Mr. Smith has worked on over 60 transactions across the healthcare sector with an aggregate transaction value of more than $15 billion. Mr. Smith earned a B.A. in Mathematical Economics from Colgate University in 2005.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --